This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Becton Dickinson and Company Limited. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Elaine Rose: Innovator in Direct Chemical Lysis
Introduction
Elaine Rose is a prominent inventor based in Raleigh, NC (US). She has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid extraction. With a total of 3 patents, her work has paved the way for more efficient and effective methods in biological sample analysis.
Latest Patents
One of Elaine's latest patents focuses on methods and compositions for direct chemical lysis. This innovative composition includes an assay compatible buffer and surfactant, which, when combined with a specimen storage composition, prevents undesired modifications to nucleic acids and proteins. The direct chemical lysis composition allows for direct nucleic acid extraction from biological samples without the need for centrifugation or prolonged high-temperature processing. This method eliminates the necessity of using proteinase K or other enzymes, streamlining the extraction process significantly.
Career Highlights
Elaine Rose is currently employed at Becton Dickinson and Company Limited, where she continues to develop her groundbreaking technologies. Her work has been instrumental in advancing the efficiency of biological assays, making them more accessible and less time-consuming.
Collaborations
Elaine has collaborated with notable colleagues, including Michael Porter and Laurence Michael Vaughan. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Elaine Rose's contributions to the field of biotechnology, particularly through her innovative patents, have significantly impacted the efficiency of nucleic acid extraction methods. Her work continues to influence the industry and improve biological sample analysis.